154 related articles for article (PubMed ID: 34404538)
1. Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation.
Nuansri S; Kantachuvesiri S; Watcharananan SP; Thongprayoon C; Cheungpasitporn W; Bruminhent J
Transplant Proc; 2021 Sep; 53(7):2267-2271. PubMed ID: 34404538
[TBL] [Abstract][Full Text] [Related]
2. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis.
Boudreault AA; Xie H; Rakita RM; Scott JD; Davis CL; Boeckh M; Limaye AP
Transpl Infect Dis; 2011 Jun; 13(3):244-9. PubMed ID: 21414119
[TBL] [Abstract][Full Text] [Related]
4. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
Arthurs SK; Eid AJ; Pedersen RA; Kremers WK; Cosio FG; Patel R; Razonable RR
Clin Infect Dis; 2008 Mar; 46(6):840-6. PubMed ID: 18260785
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
[TBL] [Abstract][Full Text] [Related]
6. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
[TBL] [Abstract][Full Text] [Related]
7. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients.
Taksinwarajarn T; Sobhonslidsuk A; Kantachuvesiri S; Thongprayoon C; Cheungpasitporn W; Bruminhent J;
Transpl Infect Dis; 2021 Aug; 23(4):e13635. PubMed ID: 33982825
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
Fernández-Ruiz M; Arias M; Campistol JM; Navarro D; Gómez-Huertas E; Gómez-Márquez G; Díaz JM; Hernández D; Bernal-Blanco G; Cofan F; Jimeno L; Franco-Esteve A; González E; Moreso FJ; Gómez-Alamillo C; Mendiluce A; Luna-Huerta E; Aguado JM;
Transpl Int; 2015 Sep; 28(9):1042-54. PubMed ID: 25864986
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for late-onset cytomegalovirus infection or disease in kidney transplant recipients.
Jamal AJ; Husain S; Li Y; Famure O; Kim SJ
Transplantation; 2014 Mar; 97(5):569-75. PubMed ID: 24398852
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
12. Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients.
Vutien P; Perkins J; Biggins SW; Reyes J; Imlay H; Limaye AP
Liver Transpl; 2021 Sep; 27(9):1302-1311. PubMed ID: 33687777
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
Blom KB; Birkeland GK; Midtvedt K; Jenssen TG; Reisæter AV; Rollag H; Hartmann A; Sagedal S; Sjaastad I; Tylden G; Njølstad G; Nilsen E; Christensen A; Åsberg A; Birkeland JA
Transplantation; 2023 Aug; 107(8):1846-1853. PubMed ID: 37211633
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
16. Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ Transplantation.
Belga S; MacDonald C; Chiang D; Kabbani D; Shojai S; Abraldes JG; Cervera C
Clin Infect Dis; 2021 Mar; 72(5):845-852. PubMed ID: 32025704
[TBL] [Abstract][Full Text] [Related]
17. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus nephritis in kidney transplant recipients: Epidemiology and outcomes of an uncommon diagnosis.
Swanson KJ; Djamali A; Jorgenson MR; Misch EA; Ghaffar A; Zhong W; Aziz F; Garg N; Mohamed M; Mandelbrot D; Parajuli S
Transpl Infect Dis; 2021 Oct; 23(5):e13702. PubMed ID: 34324253
[TBL] [Abstract][Full Text] [Related]
19. Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection?
Rahimishahmirzadi M; Jevnikar AM; House AA; Luke PP; Humar A; Silverman MS; Shalhoub SM; Hosseini-Moghaddam SM
Clin Transplant; 2021 Jun; 35(6):e14285. PubMed ID: 33713374
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
